DrugsControl Media Services
DrugsControl.org

News Detail

US FDA approves BridgeBio’s Attruby for ATTR-CM treatment (26-11-2024)

California, 26 Nov 2024: The US Food and Drug Administration (FDA) has approved View Details

Source : Pharmaceutical Technology
US Food and Drug Administration (FDA) oral transthyretin (TTR) stabiliser Attruby (acoramidis) BridgeBio Pharma

Related News